1345: Shanghai Pioneer Holding Ltd - Summary | Jitta

Shanghai Pioneer Holding Ltd

HKG:1345

Price
HK$2.20
Loss Chance
49.2%
4.87JITTA SCORE
143.83%Over Jitta Line
Jitta Ranking
169 / 236
1,624 / 2,533
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (33)
Recent Business Performance (33)
Financial Strength (73)
Return to Shareholders (70)
Competitive Advantage (36)
Jitta Signs
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 21.20% in the last year
Key Stats
Jitta Score
Jitta Line
4.87
143.83%
3.83
186.19%
Health Care Distributors
2.68
100.00%
3.93
14.34%
5.16
29.78%
COMPANY DESCRIPTION
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; sale of household appliances; and provision of metal finishing, management consulting, information consulting, and market information services. It sells its products to hospitals, medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People’s Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.